Clinical Trial Update: Study of AK156 in Primary Osteoporosis Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating AK156 for primary osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• AK156

Snippet

Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED